$TRXC News
Last published 5y ago
- 5y agoTRXCAsensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and fiscal year 2020 financial and operating results after the market closes o ...
- 5y agoTRXCAsensus Surgical Announces FDA Clearance in General SurgeryBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication exp ...
- 5y agoTRXCAsensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences ConferenceBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief ...
- 5y agoTRXCASXCTransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided SurgeryBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to Asensus Surgical, Inc. The name change reflects the company's broader vision of shaping the future of surgery by integrat ...
- 5y agoTRXCTransEnterix Announces New Training Center in EUBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has agreed to partner with the Amsterdam Skills Centre (ASC) in the Netherlands for surgical training. This site will serve surgeons and staff througho ...
- 5y agoBSGMMDTBSXTRXC+1Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027PR NewswireCardiovascular devices are the medical devices which are used to diagnosis and treat the heart diseases and other heart-related problems. These...
- 5y agoTRXCTransEnterix to Host Virtual Investor Day on February 23, 2021Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will host a virtual Investor Day on February 23, 2021, beginning at 11:00am Eastern Time.
- 5y agoTRXCTransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional SharesBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering of its common stock. Including the full exercise of the underwriter’s option to purchase addit ...
- 5y agoTRXCTransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 MillionBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm ...
- 5y agoTRXCTransEnterix Announces $25.0 Million Bought Deal Offering of Common StockBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase ...
- 5y agoSTTAONETRXCZOM+1Microcap ETFs Shunned as Reddit, Robinhood Feed Retail AddictionBloombergWith penny stocks all the rage in Reddit forums and across the Robinhood trading platform, U.S. retail investors are pulling money from microcap funds just to support the habit.
- 5y agoTRXCTransEnterix Receives CE Mark for Machine Vision System in Robotic SurgeryBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received CE Mark approval for the Intelligent Surgical UnitTM (ISUTM) that enables machine vision capabilities on the SenhanceⓇ Surgical System. This a ...
- 5y agoTRXCTransEnterix Announces Closing of $31.25 Million Registered Direct Offering of Common StockBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced registered direct offering of 25,000,000 shares of its common stock. The offering was priced at a purchase price per share ...
- 5y agoTRXCSNDLZOMOTCMWhat Investors Should Know Before Buying Surging Penny StocksBloombergShares selling for less than $1 sound like an alluring investment. But they come with serious risks such as exposure to pump-and-dump schemes.
- 5y agoTRXCZOMBIOLTonix, Biolase Join Penny Stocks Surge After Reddit ToutsBloombergTonix Pharmaceuticals Holding jumped as much as 24% early Wednesday, the latest in a group of tiny health-care stocks to get a boost in volume, after day traders touted the company on message boards for no apparent reason.
- 5y agoTRXCTransEnterix Announces $31.25 Million Registered Direct Offering of Common StockBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into securities purchase agreements with several institutional investors for the purchase and sale, in a registered direct offering of 25,000,0 ...
- 5y agoSIGLZOMISRGTRXCDay Traders Lighting Up Reddit Spur Rally in Tiny Health StocksBloombergTransEnterix Inc. almost doubled, climbing as much as 97% on Monday, as day traders drove heady gains in a handful of health-care stocks.
- 5y agoTRXCTransEnterix Provides Preliminary 2020 Year-End Corporate UpdateBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today provided a preliminary 2020 year-end corporate update.
- 5y agoTRXCTransEnterix to Participate in Two Upcoming Virtual Healthcare ConferencesBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at two upcoming virtual investor conferences:
- 5y agoTRXCTransEnterix Announces Southern Surgical Hospital to Initiate a Senhance® Digital Laparoscopic ProgramBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Southern Surgical Hospital has entered into an agreement to lease and utilize a Senhance® Surgical System.
- 5y agoTRXCTransEnterix Announces Approval of Senhance® Surgical System in Russian FederationBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Senhance® Surgical System has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale ...
- 6y agoTRXCTransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2020Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2020.
- 6y agoTRXCTransEnterix to Present at the Stifel 2020 Virtual Healthcare ConferenceBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the Stifel 2020 Virtual Healthcare Conference. The virtual presentation is scheduled to take place at 4:00 pm Eastern Time, Tuesday, November ...
- 6y agoTRXCTransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 5, 2020Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release third quarter financial and operating results after the market closes on Thursday, November 5, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.
- 6y agoTRXCTransEnterix Announces First Pediatric Surgical Cases with Senhance® Surgical SystemBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that surgeons at Maastricht University Medical Center+ (MUMC+) in the Netherlands, have successfully operated on multiple pediatric patients, becoming the first pe ...
- 6y agoTRXCTransEnterix Announces Toshima Hospital in Japan to Initiate a Senhance® Digital Laparoscopy ProgramBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Toshima Hospital of the Tokyo Metropolitan Health and Hospitals Corporation has entered into an agreement to lease and utilize a Senhance® Surgical System ...
- 6y agoTRXCTransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision CapabilitiesBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Hackensack Meridian Health Pascack Valley Medical Center, a hospital in New Jersey, successfully completed its first surgical procedures using the Intelligent ...
- 6y agoTRXCTransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical SystemBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it established the first training center for the Senhance® Surgical System in the Asia-Pacific region in Japan at the Saitama Medical University International ...
- 6y agoTRXCTransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment ConferenceBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the H. C. Wainwright 22nd Annual Global Investment Conference. The presentation is scheduled to take place virtually at 3:00 PM Eastern, Tuesda ...
- 6y agoTRXCTransEnterix Announces New Employment Inducement GrantBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that in connection with the appointment of Shameze Rampertab as the Company’s Executive Vice President and Chief Financial Officer effective August 24, 2020, the ...
- 6y agoTRXCTransEnterix Announces Appointment of Shameze Rampertab as Chief Financial OfficerBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Shameze Rampertab has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective August 24, 2020.
- 6y agoTRXCTransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2020Business WireRESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the second quarter of 2020.
- 6y agoTRXCTransEnterix Announces Submission of General Surgery Expansion in the USBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has submitted an indications filing to the FDA to expand General Surgery usage of the Senhance Surgical System.
- 6y agoTRXCTransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance Surgical SystemBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Maastricht University Medical Center+ (MUMC+) has entered into an agreement to lease and utilize a Senhance® Surgical System, which would be the first hospita ...
- 6y agoTRXCTransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2020Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release second quarter financial and operating results after the market closes on Wednesday, August 5, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.
- 6y agoTRXCTransEnterix Announces Closing of $15.0 Million Underwritten Public Offering including Full Exercise of Over-Allotment OptionBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering, with total gross proceeds of approximately $15.0 million, which includes the full exercise o ...
- 6y agoTRXCTransEnterix Announces Pricing of $13.0 Million Underwritten Public Offering of Common StockBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has priced its previously announced underwritten offering of common stock, comprised of 37,267,080 shares of common stock at a public offering price of $0 ...
- 6y agoTRXCTransEnterix Announces Launch of Underwritten Public Offering of Common StockBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has commenced an underwritten offering of common stock.
- 6y agoTRXCTransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical SystemBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Sana Klinikum Offenbach has entered into an agreement to lease and utilize a Senhance® Surgical System. Located in the city of Offenbach am Main, the hosp ...
- 6y agoTRXCTransEnterix Announces Sinai Health System in Chicago to Initiate Program with the Senhance Surgical SystemBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Sinai Health System in Chicago has entered into an agreement to lease and utilize a Senhance® Surgical System, which would be the first facility in Chicag ...
- 6y agoTRXCTransEnterix, Inc. (TRXC) CEO Anthony Fernando on Q1 2020 Results - Earnings Call TranscriptEarnings Call Transcripts
- 6y agoTRXCTransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2020Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the first quarter of 2020.
- 6y agoTRXCTransEnterix Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2020Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release first quarter financial and operating results before the market opens on Thursday, May 14, 2020. The Company will host a conference call to discuss these results starting at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast.
- 6y agoTRXCTransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2019Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and full-year 2019.
- 6y agoTRXCTransEnterix Receives FDA Clearance for First Machine Vision System in Robotic SurgeryBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received 510(k) clearance for the Intelligent Surgical Unit (ISUTM) that enables machine vision capabilities on the SenhanceⓇ Surgical System.
- 6y agoTRXCTransEnterix Schedules Fourth Quarter and Fiscal Year 2019 Financial and Operating Results Conference Call for March 16, 2020Business WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter financial and Fiscal year 2019 operating results after the market closes on Monday, March 16, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.
- 6y agoTRXCTransEnterix Announces Pricing of $15 Million Underwritten Public OfferingBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has priced its previously announced underwritten offering of units. The offering was comprised of (i) units of common stock and warrants to purchase share ...
- 6y agoTRXCTransEnterix Announces Launch of Underwritten Public OfferingBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has commenced an underwritten offering of units. The offering is expected to be comprised of (i) a unit of common stock and warrants to purchase shares of ...
- 6y agoTRXCTransEnterix Announces St. Marianna University School of Medicine Toyoko Hospital in Japan to Initiate a Senhance Digital Laparoscopy ProgramBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the St. Marianna University School of Medicine Toyoko Hospital, a hospital in the greater Tokyo metropolitan area, has entered into an agreement to lease and ...
- 6y agoTRXCTransEnterix Announces Kitakyushu General Hospital Completes First Surgical Procedures with the Senhance Surgical SystemBusiness WireRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Kitakyushu General Hospital, a hospital in southwestern Japan, completed its first surgical procedures using the Senhance® Surgical System. The first pati ...